[go: up one dir, main page]

MX2013008995A - Composicion farmaceutica para el tratamiento del dolor. - Google Patents

Composicion farmaceutica para el tratamiento del dolor.

Info

Publication number
MX2013008995A
MX2013008995A MX2013008995A MX2013008995A MX2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A MX 2013008995 A MX2013008995 A MX 2013008995A
Authority
MX
Mexico
Prior art keywords
inflammatory
pharmaceutical composition
pharmaceutically acceptable
acceptable salts
treating pain
Prior art date
Application number
MX2013008995A
Other languages
English (en)
Inventor
Federico Amezcua Amezcua
Amador Covarrubias Pinedo
Original Assignee
Raam De Sahuayo S A De C V Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raam De Sahuayo S A De C V Lab filed Critical Raam De Sahuayo S A De C V Lab
Priority to MX2013008995A priority Critical patent/MX2013008995A/es
Publication of MX2013008995A publication Critical patent/MX2013008995A/es
Priority to PCT/MX2014/000115 priority patent/WO2015016696A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a una combinación sinérgica con efecto analgésico, antiinflamatorio y antipirético potencializado que comprende a) al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables; y, b) al menos un antiinflamatorio del grupo de los salicilatos. Además, se refiere a una composición farmacéutica que comprende al menos un núcleo de liberación retardada y/o liberación inmediata que contiene al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables y/o al menos un antiinflamatorio del grupo de los salicilatos; y al menos dos capas de liberación inmediata y/o prolongada que contienen al menos un antiinflamatorio no esteroideo y/o sus sales farmacéuticamente aceptables y/o al menos un antiinflamatorio del grupo de los salicilatos.
MX2013008995A 2013-08-02 2013-08-02 Composicion farmaceutica para el tratamiento del dolor. MX2013008995A (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013008995A MX2013008995A (es) 2013-08-02 2013-08-02 Composicion farmaceutica para el tratamiento del dolor.
PCT/MX2014/000115 WO2015016696A1 (es) 2013-08-02 2014-07-24 Composición farmacéutica para el tratamiento del dolor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013008995A MX2013008995A (es) 2013-08-02 2013-08-02 Composicion farmaceutica para el tratamiento del dolor.

Publications (1)

Publication Number Publication Date
MX2013008995A true MX2013008995A (es) 2014-03-24

Family

ID=50935220

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013008995A MX2013008995A (es) 2013-08-02 2013-08-02 Composicion farmaceutica para el tratamiento del dolor.

Country Status (2)

Country Link
MX (1) MX2013008995A (es)
WO (1) WO2015016696A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU170329B (es) * 1974-12-12 1977-05-28
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
US6277362B1 (en) * 1999-10-26 2001-08-21 Isw, Inc. After shave treatment preparation
US20040077609A1 (en) * 2001-01-16 2004-04-22 Michael Rubin Oral composition containing NSAIDs and essential oils
EA020867B1 (ru) * 2006-03-06 2015-02-27 Поузен Инк. Лекарственные формы для введения комбинаций лекарственных средств
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination

Also Published As

Publication number Publication date
WO2015016696A1 (es) 2015-02-05

Similar Documents

Publication Publication Date Title
MX2021003230A (es) Composiciones farmaceuticas que comprenden meloxicam.
MY196173A (en) Cot Modulators And Methods Of Use Thereof
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
CL2018000222A1 (es) Nueva combinación para el uso en el tratamiento del cáncer
BR112015020466A2 (pt) inibidores de cdc7
MX2016008429A (es) Derivado de piranocromenil fenol, y composicion farmaceutica para tratar un sindrome metabolico o enfermedad inflamatoria.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
EA201491039A1 (ru) Комбинации диацереина и нестероидных противовоспалительных лекарственных средств
HK1231390A1 (zh) 用於局部给药的药用组合物
PH12015501783B1 (en) Pharmaceutical compositions for the treatment of helicobacter pylori
NZ735777A (en) Methods and compositions to inhibit symptoms associated with veisalgia
PH12016500910A1 (en) Long-acting ketoprofen compositions
MX373177B (es) Métodos de tratamiento de disquinesia y trastornos relacionados.
WO2015004634A3 (es) Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
MX2013008995A (es) Composicion farmaceutica para el tratamiento del dolor.
CL2016002655A1 (es) Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol
EA201692426A1 (ru) Комбинации зальтопрофена и миорелаксанта
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol
IN2013MU03428A (es)
GT201300318A (es) Composición farmacéutica para uso en inflamación y dolor
MX2014011922A (es) Composicion para el tratamiento de desordenes inflamantorios e inmunes.
MX2013008993A (es) Sistema de liberacion modificada en tres fases de un antiinflamatorio no esteroide.
MX2015014063A (es) Composicion anti tumoral que comprende un inhibidor selectivo pi3kbeta y un inhibidor selectivo pi3kalfa.
WO2012016314A9 (pt) Compostos derivados do ácido araquidônico substituídos com análogos de coxibes para tratamento de dor